(Q33922708)

English

Apolipoprotein E, smooth muscle cells and the pathogenesis of cerebral amyloid angiopathy: the potential role of impaired cerebrovascular A beta clearance

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

Apolipoprotein E, smooth muscle cells and the pathogenesis of cerebral amyloid angiopathy: the potential role of impaired cerebrovascular A beta clearance (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

cerebral amyloid angiopathy

1 reference

based on heuristic

inferred from title

author name string

Prior R

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Wihl G

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Urmoneit B

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

1 April 2000

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Annals of the New York Academy of Sciences

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

903

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

180-186

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06367.X

21 January 2018

Differential cellular accumulation/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglycans. Apolipoproteins E3 and E2 greater than e4.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06367.X

21 January 2018

Apolipoprotein E isoform-specific reduction of extracellular amyloid in neuronal cultures

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06367.X

21 January 2018

Amyloid beta-protein deposition in the leptomeninges and cerebral cortex.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06367.X

21 January 2018

Amyloid beta-proteins 1-40 and 1-42(43) in the soluble fraction of extra- and intracranial blood vessels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06367.X

21 January 2018

Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06367.X

21 January 2018

An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06367.X

21 January 2018

Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2000.TB06367.X

21 January 2018

Identifiers

10.1111/J.1749-6632.2000.TB06367.X

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33922708&oldid=1629600913"